References
- Barrett-Connor E, Bush T L. Estrogen and coronary heart disease in women. J Am Med Assoc 1991; 265: 1861–7
- Gordon T, Castelli W P, Hjortland M C, et al. Menopause and coronary heart disease: the Framingham Study. Ann Intern Med 1978; 89: 157–61
- Sullivan J M. Hormone replacement therapy and cardiovascular disease: the human model. Br J Obstet Gynecol 1996; 103: 59–67
- Bush T L. The epidemiology of cardiovascular disease in postmenopausal women. Ann N Y Acad Sci USA 1990; 592: 263–71
- Bourne T H, Hillard T C, Whitehead M I, et al. Oestrogen, arterial status and postmenopausal woman. Lancet 1990; 95: 581–8
- De Zeigler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of oestradiol and progesterone. Fertil Steril 1991; 55: 775–9
- Horwitz K B, Horwitz L D. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J Clin Invest 1982; 69: 750–8
- Mijatovic V, Pines A. Menopause-induced changes in cardiovascular functions and HRT. Eur Menopause J 1995; 2: 4–9
- Hillard T C, Crayford T B, Bourne T H, et al. Differential effects of transdermal estradiol and sequential progestogens on impedence to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992; 58: 959–64
- Penotti M, Farina M, Sironi L, et al. Cerebral artery blood flow in relation to age and menopausal status. Obstet Gynecol 1996; 88: 106–9
- Gangar K F, Vyas S, Whitehead M I, et al. Pulsatility index in the internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839–42
- Belfort M A, Saade G R, Snabes M, et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995; 172: 1273–9
- Moncada S, Vane J R. Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N Engl J Med 1979; 300: 1142–6
- Balteskard L, Brox J H, Osterud B. Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men. Atherosclerosis 1993; 102: 91–8
- Luzi G, Coata G, Cucchia G C, et al. Doppler study of uterine arteries in spontaneous and artificially induced menopausal women. Ultrasound Obstet Gynecol 1993; 3: 354–6
- Nastri M N, Shepherd J H, Setchell M E, et al. Sonographic depiction of postmenopausal endometrium with transabdominal and transvaginal scanning. Ultrasound Obstet Gynecol 1991; 1: 279–83
- Lizzi F L, Mortimer A J. Bioeffects considerations for the safety of diagnostic ultrasound. J Ultrasound Med 1988; 7: 1–38
- Battaglia C, Artini P G, Bencini S, et al. Doppler analysis of uterine blood flow changes in spontaneous and medically induced menopause. Gynecol Endocrinol 1995; 9: 143–8
- Battaglia C, Artini P G, D'Ambrogio G, et al. Uterine and ovarian blood flow measurement. Does the full bladder modify the flow resistance?. Acta Obstet Gynecol Scand 1994; 73: 716–18
- Battaglia C, Artini P G, Ballestri M, et al. Hemodynamic, hematological and hemorrheological evaluation of post-term pregnancy. Acta Obstet Gynecol Scand 1995; 74: 336–40
- Pines A, Fiwsman E Z, Averbuch M, et al. The effects of hormone replacement therapy in normal postmenopausal woman: measurements of Doppler derived parameters of aortic flow. Am J Obstet Gynecol 1991; 164: 806–12
- Still J G, Greiss F C. The effect of prostaglandins and other vasoactive substances on uterine blood flow and myometrial activity. Am J Obstet Gynecol 1978; 130: 1–8
- Balteskard L, Brox J H, Osterud B. Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men. Atherosclerosis 1993; 102: 91–8
- Aune B, Oian P, Omsjo I, et al. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood – A beneficial effect on atherogenesis and thrombus formation?. Am J Obstet Gynecol 1995; 1: 1816–20
- Kimura T, Yoshida Y, Toda N. Mechanisms of relaxation induced by prostaglandins in isolated canine uterine arteries. Am J Obstet Gynecol 1992; 176: 1409–16
- Meilahn E N, Kuller L H, Matthews K A, et al. Hemostatic factors according to menopausal status and use of hormonal replacement therapy. Ann Epidemiol 1992; 2: 445–55
- Nablusi A A, Folsom A R, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The atherosclerosis risk in communities study investigators. N Engl J Med 1993; 328: 1069–75